Published in Hum Pathol on April 01, 2000
Expression of galectins in cancer: a critical review. Glycoconj J (2004) 1.28
Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol (2010) 1.14
Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci (2007) 1.11
Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China. Diagn Pathol (2011) 1.02
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas. PLoS One (2011) 1.02
The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma. J Cancer Res Clin Oncol (2012) 0.91
Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Virchows Arch (2010) 0.80
Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Wien Klin Wochenschr (2014) 0.80
The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase. PLoS One (2011) 0.78
The Immunocytochemistry Is a Valuable Tool in the Diagnosis of Papillary Thyroid Cancer in FNA's Using Liquid-Based Cytology. J Oncol (2010) 0.77
Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms. J Clin Diagn Res (2016) 0.75
Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy. Int J Endocrinol (2015) 0.75
Serum Galectin-3: diagnostic value for papillary thyroid carcinoma. Ulus Cerrahi Derg (2015) 0.75
Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis. Onco Targets Ther (2016) 0.75
Endoscopic mucosal resection for treatment of early gastric cancer. Gut (2001) 8.70
Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry (1995) 6.40
Improved thermodynamic parameters and helix initiation factor to predict stability of DNA duplexes. Nucleic Acids Res (1996) 5.16
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology (2000) 3.50
Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer (1996) 3.21
Species-specific bird functions in a forest-canopy food web. Proc Biol Sci (2000) 2.56
Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A (1994) 2.49
Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res (1993) 2.39
Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol (1991) 2.37
New cephalosporin derivatives with high antibacterial activities. Chem Pharm Bull (Tokyo) (1977) 2.33
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron (1996) 2.27
Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21
Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology (2001) 2.10
Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer (2000) 2.09
Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology (1997) 2.07
Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br (2001) 2.07
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology (2001) 2.02
Total cavopulmonary shunt operation in complex cardiac anomalies. A new operation. J Thorac Cardiovasc Surg (1984) 2.01
A carbonic anhydrase from the nacreous layer in oyster pearls. Proc Natl Acad Sci U S A (1996) 1.97
Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child (1980) 1.96
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer (2003) 1.95
Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst (1996) 1.93
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer (2008) 1.93
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Low dose intrathecal morphine and pain relief following caesarean section. Int J Obstet Anesth (1994) 1.90
Effects of drift- and benthic-foraging fish on the drift dispersal of three species of mayfly nymphs in a Japanese stream. Oecologia (1999) 1.88
Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst (1999) 1.85
Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol (1999) 1.84
Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer (1985) 1.84
A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82
Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer (2004) 1.80
Thermodynamics-structure relationship of single mismatches in RNA/DNA duplexes. Biochemistry (2000) 1.79
An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg (1998) 1.71
Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg (1994) 1.71
Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med (2000) 1.69
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer (2004) 1.67
Right-sided partial sternotomy for minimally invasive valve operation: "open door method". Ann Thorac Surg (1998) 1.66
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res (1998) 1.66
MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol (2005) 1.65
Response of patients with cirrhosis who have undergone partial hepatectomy to treatment aimed at achieving supranormal oxygen delivery and consumption. Surgery (1998) 1.61
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60
Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol (1987) 1.59
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. Br J Cancer (2008) 1.58
Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation (1990) 1.56
Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res (2001) 1.56
Causes of nitrous oxide contamination in operating rooms. Anesthesiology (1999) 1.54
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab (2001) 1.54
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol (2001) 1.52
Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol (2000) 1.52
Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther (1998) 1.51
Cloning and molecular characterization of the gene rimL which encodes an enzyme acetylating ribosomal protein L12 of Escherichia coli K12. Mol Gen Genet (1989) 1.51
Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. J Nucl Med (1992) 1.48
Evaluation of right ventricular function by regional wall motion analysis in patients after correction of tetralogy of Fallot. Comparison of transventricular and nontransventricular repairs. J Thorac Cardiovasc Surg (1992) 1.48
Dietary patterns and depressive symptoms among Japanese men and women. Eur J Clin Nutr (2010) 1.46
Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions. Br J Haematol (1997) 1.46
Polyamine-promoted autoactivation of plasma hyaluronan-binding protein. J Thromb Haemost (2009) 1.44
Favorable strategy for the ostial lesion of the left anterior descending coronary artery: influence on narrowing of circumflex coronary artery. Cathet Cardiovasc Diagn (1998) 1.42
The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer (1996) 1.41
Variation in glycosaminoglycan components of breast tumors. Cancer Res (1976) 1.40
The use of double-straight needle device in laparoscopic incisional and ventral hernia repair. Surg Laparosc Endosc Percutan Tech (2000) 1.40
Production of anti-cardiolipin antibody in AKR/J mice with streptozocin-induced insulitis and diabetes. Diabetes Res Clin Pract (1993) 1.40
Treatment of renovascular hypertension using stent implantation in an elderly patient with NIDDM. Intern Med (2000) 1.40
Epstein-Barr virus in gastric carcinoma. Am J Pathol (1993) 1.40
Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer (2008) 1.39
Reduction of thickness of ganglion cell complex after internal limiting membrane peeling during vitrectomy for idiopathic macular hole. Eye (Lond) (2012) 1.39
Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis. J Nucl Med (1991) 1.39
Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol (1994) 1.39
Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol (1997) 1.39
Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol (1993) 1.39
Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res (1995) 1.39
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer (2008) 1.39
Painless thyroiditis occurring during long-term treatment with interferon alfa in a patient with chronic active hepatitis C. South Med J (1996) 1.38
Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer (1993) 1.37
SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene (2006) 1.37
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br J Cancer (2007) 1.34
Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer (2000) 1.34
Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer (1996) 1.33
Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. J Natl Cancer Inst (1982) 1.32
Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res (1989) 1.32
Why is the interferon sensitivity-determining region (ISDR) system useful in Japan? J Hepatol (1999) 1.31
Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology (1999) 1.30
Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int (1997) 1.30
Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol (1993) 1.29
Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site. Neurosurgery (1996) 1.28
Elastofibromatous lesion of the stomach in a patient with elastofibroma dorsi. Am J Surg Pathol (1985) 1.26
Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett (2000) 1.26
Sodium thiosulfate solution spray for relief of irritation caused by Lugol's stain in chromoendoscopy. Gastrointest Endosc (2001) 1.26
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer. Br J Cancer (2008) 1.25
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol (2001) 1.25
Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol (1999) 1.24